Nicotine dependence in an isolated population of Kashubians from North Poland: a population survey

BMC Public Health

Karolina Kita-Milczarska¹  Ewa Jassem¹  Alicja Sieminska¹ 

[1] Department of Allergology and Pneumonology, Medical University of Gdansk, Debinki Str. 7, Gdansk, 80-211, Poland

关键词: Polymorphism;    Nicotinic receptor subunit;    Demographic;    Population survey;    Nicotine dependence;   

Others  :  1121526
DOI  :  10.1186/s12889-015-1455-5

 received in 2014-10-16, accepted in 2015-01-22,  发布年份 2015

【 摘 要 】

Background

Tobacco use is a complex, multistage behaviour. The particular stages of this behaviour, including nicotine dependence (ND), are influenced by both genetics and the environment. Surveys on factors influencing tobacco use and ND, conducted in ethnically homogenous populations, can provide results less influenced by genetic and cultural heterogeneity. We aimed to assess ND in a sample of current smokers, derived from the geographically and culturally isolated population of Kashubians from North Poland, and evaluate its potential association with age, sex, and self-reported comorbidities. In addition, we attempted to replicate - for the first time in this population - previous findings on the association between ND and several variants within the CHRNA5A3-A5-B4 nicotine receptor subunit gene cluster.

Methods

The study sample consisted of 969 unrelated subjects who were all current smokers. ND was evaluated using four measures: the Fagerstrom Test for Nicotine Dependence (FTND), the Heavy Smoking Index (HSI), the number of cigarettes per day (CPD) and the time to first cigarette after waking (TTF). All subjects underwent genotyping for CHRNA5 rs16969968, CHRNA3 rs578776, and CHRNB4 rs12914008 variants. Multivariate regression analysis was used for the assessment of the studied correlations. A significance level of 0.05 with the Bonferroni correction for multiple testing was set for a type 1 error in the analyses.

Results

The mean CPD, FTND and HSI scores in the study sample were 17.3 ± 7.7, 3.9 ± 2.3 and 2.6 ± 1.5, respectively. No association between ND defined by FTND, HSI or TTF and age was found. In turn, heavy smoking was significantly associated with older age (odds ratio (OR) = 1.72, 95% confidence interval (CI): 1.14-2.59, p = 0.009), and men were more likely than women to be heavy smokers (OR = 1.70, 95% CI: 1.09-2.65, p = 0.018). Chronic comorbidity did not significantly influence ND. An analysis of association of studied polymorphisms with ND showed a borderline association of rs16969968 with CPD (OR = 1.63, 95% CI: 1.09–2.45, p = 0.017).

Conclusion

Our study showed a low to moderate level of ND in the Kashubians, influenced by age, sex, as well as the CHRNA5 rs16969968 variant.

【 授权许可】

   
2015 Sieminska et al.; licensee BioMed Central.

【 参考文献 】

• [1]Eriksen M, Mackay J, Ross H: Tobacco Atlas. 4th edition. WHO, Geneva; 2011.
• [2]Johnson EO, Chase GA, Breslau N: Persistence of cigarette smoking: familial liability and the role of nicotine dependence. Addiction 2002, 97:1063-70.
• [3]Ho MK, Tyndale RF: Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J 2007, 7:81-98.
• [4]Mayhew KP, Flay BR, Mott JA: Stages in the development of adolescent smoking. Drug Alcohol Depend 2000, 59(Suppl 1):61-81.
• [5]True WR, Heath AC, Scherrer JF, Waterman B, Goldberg J, Lin N, et al.: Genetic and environmental contributions to smoking. Addiction 1997, 92:1277-87.
• [6]Kendler KS, Thornton LM, Pederson NL: Tobacco consumption in Swedish twins reared apart and reared together. Arch Gen Psychatry 2001, 57:886-92.
• [7]Lessov CN, Martin NG, Statham DJ, Todorov AA, Slutske WS, Bucholz KK, et al.: Defining nicotine dependence for genetic research: Evidence from Australian twins. Psychol Med 2004, 34:865-79.
• [8]Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE: Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 2008, 75:178-95.
• [9]Munafό MR, Johnstone EC: Genes and cigarette smoking. Addiction 2008, 103:893-904.
• [10]Maes HH, Sullivan PF, Bulik CM, Neale MC, Prescott CA, Eaves LJ, et al.: A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol Med 2004, 34:1251-61.
• [11]Li MD: The genetics of nicotine dependence. Curr Psychiatry Rep 2006, 8:158-64.
• [12]Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, et al.: Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 2007, 16:24-35.
• [13]Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, et al.: Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 2007, 16:36-49.
• [14]Stolerman IP, Jarvis MJ: The scientific case that nicotine is addictive. Psychopharmacology (Berl) 1995, 117:2-10.
• [15]Pidoplichko VI, DeBiasi M, Williams JT, Dani JA: Nicotine activated and desensitizes midbrain dopamine neurons. Nature 1997, 390:401-4.
• [16]Salokangas RK, Vilkman H, Ilonen T, Taiminen T, Bergman J, Haaparanta M, et al.: High levels of dopamine activity in the basal ganglia of cigarettes smokers. Am J Psychiatry 2000, 157:632-4.
• [17]Koob GF: Neural mechanisms of drug reinforcement. Ann NY Acad Sci 1992, 654:171-91.
• [18]Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO: The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict 1991, 86:1119-27.
• [19]Heatherton TF, Kozlowski LT, Frecker RC, Rickert W, Robinson J: Measuring the heaviness of smoking: using self-reported time to the first cigarette of the day and number of cigarettes smoked per day. Br J Addict 1989, 84:791-9.
• [20]Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, et al.: Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 2008, 165:1163-71.
• [21]Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H, et al.: Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 2008, 13:368-73.
• [22]Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, et al.: A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 2008, 4:e1000125.
• [23]Saccone NL, Wang JC, Breslau N, Johnson EO, Hatsukami D, Saccone SF, et al.: The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and European-Americans. Cancer Res 2009, 69:6848-56.
• [24]Saccone NL, Culverhouse RC, Schwantes-An TH, Cannon DA, Chen X, Cichon S, et al.: Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta analysis and comparison with lung cancer and COPD. PLoS Genet 2010, 6:e1001053.
• [25]Sarginson JE, Killen JD, Lazerroni LC, Fortman SP, Ryan HS, Schatzberg AF, et al.: Markers in the 15q24 nicotine receptor subunit gene cluster (CHRNA5-A3-B4) predict severity of nicotine addiction and response to smoking cessation therapy. Am J Med Genet Part B Neuropsychiatr Genet 2011, 156B:275-84.
• [26]Caporaso N, Gu F, Chatterjee N, Sheng-Chih J, Yu K, Yeager M, et al.: Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 2009, 4:e4653.
• [27]Ware JJ, van den Bree MB, Munafò MR: Association of the CHRNA5-A3-B4 gene cluster with heaviness of smoking: a meta-analysis. Nicotine Tob Res 2011, 13:1167-75.
• [28]Chen LS, Saccone NL, Culverhouse RC, Bracci PM, Chen CH, Dueker N, et al.: Smoking and genetic risk variation across populations of European, Asian, and African American ancestry–a meta-analysis of chromosome 15q25. Genet Epidemiol 2012, 36:340-51.
• [29]Broms U, Wedenoja J, Largeau MR, Korhonen T, Pitkäniemi J, Keskitalo-Vuokko K, et al.: Analysis of detailed phenotype profiles reveals CHRNA5-CHRNA3-CHRNB4 gene cluster association with several nicotine dependence traits. Nicotine Tob Res 2012, 14:720-33.
• [30]Pearce MS, Mann KD, Singh G, Davison B, Sayers SM: Prevalence and validity of self-reported smoking in Indigenous and non-Indigenous young adults in the Australian Northern Territory. BMC Public Health 2014, 14:861. BioMed Central Full Text
• [31]Unger JB: Cultural influences on substance use among Hispanic adolescents and young adults: findings from Project RED. Child Dev Perspect 2014, 8:48-53.
• [32]Wyniki Narodowego Spisu Powszechnego Ludności i Mieszkań, 2011. Podstawowe informacje o sytuacji demograficzno-społecznej ludności Polski oraz zasobów mieszkaniowych. [Results of the General Census and the Housing Stock Assessment, 2011. Basic information related to the socio-demographics of Polish population and the housing stock]. Central Statistical Office 2011. http://www.kaszubi.pl/images/dodatkowe/aktualnosci/Wyniki_demograficzne_spisu_2011_-_f.pdf
• [33]Fagerstrom KO: Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978, 3:235-41.
• [34]Schiffman S: Tobacco “chippers” – individual differences in tobacco dependence. Psychopharmacology (Berl) 1989, 97:539-47.
• [35]Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-5.
• [36]Giovino GA, Mirza SA, Samet JM, Gupta PC, Jarvis MJ, Bjala N, et al.: Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys. Lancet 2012, 380:668-79.
• [37]Royce JM, Corbett K, Sorensen G, Ockene J: Gender, social presuure, and smoking cessations: the Community Intervention Trial for Smoking Cessation (COMMIT) at baseline. Soc Sci Med 1997, 44:359-70.
• [38]Champagne BM, Sebrié EM, Schargrodsky H, Pramparo P, Boissonnet C, Wilson E: Tobacco smoking in seven Latin American cities: the CARMELA study. Tob Control 2010, 19:457-62.
• [39]Hukkinen M, Kaprio J, Broms U, Koskenvuo M, Korhonen T: Characteristics and consistency of light smoking: long-term follow-up among Finnish adults. Nicotine Tob Res 2009, 11:797-805.
• [40]Filippidis FT, Vardavas CI, Loukopoulou A, Behrakis P, Connolly GN, Tountas Y: Prevalence and determinants of tobacco use among adults in Greece: 4 year trends. Eur J Public Health 2013, 23:772-6.
• [41]Memon A, Moody PM, Sugathan TN, el-Gerges N, Al-Bustan M, al-Shatti A, et al.: Epidemiology of smoking among Kuwaiti adults: prevalence, characteristics, and attitudes. Bull World Health Organ 2000, 78:1306-15.
• [42]Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al.: Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 2008, 10:1691-715.
• [43]John U, Meyer C, Rumpf HJ, Hapke U: Smoking, nicotine dependence and psychiatric comorbidity–a population-based study including smoking cessation after three years. Drug Alcohol Depend 2004, 6:287-95.
• [44]Wehring HJ, Liu F, McMahon RP, Mackowick KM, Love RC, Dixon L, et al.: Clinical characteristics of heavy and non-heavy smokers with schizophrenia. Schizophr Res 2012, 138:285-9.
• [45]Haustein KO, Haffner S, Woodcock BG: A review of the pharmacological and psychopharmacological aspects of smoking and smoking cessation in psychiatric patients. Int J Clin Pharmacol Ther 2002, 40:404-18.
• [46]Richardson CG, Ratner PA: A confirmatory factor analysis of the Fagerström Test for Nicotine Dependence (FTND). Addict Behav 2005, 30:697-709.
• [47]Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, et al.: Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992, 12:2765-84.
• [48]Conlon MS, Bewick MA: Single nucleotide polymorphisms in CHRNA5 rs16969968, CHRNA3 rs578776, and LOC123688 rs8034191 are associated with heaviness of smoking in women in Northeastern Ontario, Canada. Nicot Tob Res 2011, 13:1076-83.
• [49]Moolchan ET, Radzius A, Epstein DH, Uhl G, Gorelic DA, Cadet JL, et al.: The Fagerstrom test for nicotine dependence and the diagnostic interview schedule: do they diagnose the same smokers? Addict Bahav 2002, 27:101-13.
• [50]Shadel WG, Shiffman S, Niaura R, Nichter M, Abrams DB: Current models of nicotine dependence: what is known and what is needed to advance understanding of tobacco etiology among youth. Drug Alcohol Dependence 2000, 59(Suppl 1):S9-22.
• [51]Etter JF, Duc TV, Perneger TV: Validity of the Fagerström test for nicotine dependence and of the Heaviness of Smoking Index among relatively light smokers. Addiction 1999, 94:269-81.
• [52]Etter JF: A comparison of the content-, construct- and predictive validity of the cigarette dependence scale and the Fagerström test for nicotine dependence. Drug Alcohol Depend 2005, 77:259-68.
• [53]Dijkstra A, Tromp D: Is the FTND a measure of physical as well psychological tobacco dependence? J Subst Abuse Treat 2002, 23:367-74.
• [54]DiFranza JR, Wellman RJ, Savageau JA, Beccia A, Ursprung WW, McMillen R. What aspect of dependence does the Fagerström Test for Nicotine Dependence measure? Hindawi Publishing Corporation, ISRN Addiction, 2013:Article ID 906276, http://dx.doi.org/10.1155/2013/906276
• [55]Lerman C, Swan GE: Non-replication of genetic association studies: is DAT all, folks? Nicot Tob Res 2002, 4:247-9.
• [56]Chaiton MO, Cohen JE, McDonald PW, Bondy SJ: The Heaviness of Smoking Index as a predictor of smoking cessation in Canada. Addict Behav 2007, 32:1031-42.
• [57]Pennanen M, Broms U, Korhonen T, Haukkala A, Partonen T, Tuulio-Henriksson A, et al.: Smoking, nicotine dependence and nicotine intake by socio-economic status and marital status. Addict Behav 2014, 39:1145-51.
• [58]Cardon LR, Bell JI: Association study designs for complex diseases. Nat Rev Genet 2001, 2:91-9.
• [59]Li MD, Yoon D, Lee J-Y, Han B-G, Niu T, Payne TJ, et al.: Associations of variants in CHRNA5/A3/B4 gene cluster with smoking behaviors in a Korean population. PLoS One 2010, 5:e12183.
• [60]Patrick DL, Cheadle A, Thompson DC, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. Am J Public Health 1994, 84:1086-93.